Dr. Benjamin Diamond (@BenDiamondMD) will present new findings from the ReKInDLE study at #ASH25, presenting a potential path forward for early relapse/refractory #MultipleMyeloma patients. Learn more about our presence: https://t.co/FndtbHJoUV.
#Myeloma Paper of the Day: Diagnostic sequencing identifies high-risk markers + resistance mechanisms (Cereblon pathway alterations in 24.3% of IMiD-treated pts, del 4p (CD38) in pts post-anti-CD38, BCMA deletions & mutations pts txd w/ anti-BCMA: https://t.co/dWPLkdGZRc. #mmsm
At Sylvester Myeloma Institute, we don’t just imagine a multiple myeloma cure, we are building the path to it. Driven by innovation, excellence and collaboration, our globally recognized scientists and clinicians are advancing the transformative therapies of tomorrow.
From pioneering clinical trials and computational advancements to training the next generation of myeloma leaders through our Advanced Clinical and Computational Fellowships and International Scholars Program, Sylvester is where myeloma talent thrives and drives impact to improve patients’ lives. #mmsm
Come join our team: https://t.co/T503z0tbhV
@DrOlaLandgren
For Rare Disease Day this Friday, we spoke with @DrSarahGooding, a clinician scientist in @Chapman_lab_UK at the MRC WIMM researching multiple myeloma, a currently incurable type of bone marrow cancer that desperately requires friendlier therapies.
Watch: https://t.co/I52UPz4lPP
In 2005, Rafat Abonour (@rabonour1), MD, set out to find answers for his patients battling multiple myeloma — and that mission fueled his desire to launch Miles for Myeloma. Since then, this event has raised $8.3 million to support research. Learn more: https://t.co/Ue40iirU2x.
#Myeloma Paper of the Day: #MGUS risk stratification models can be applied longitudinally to repeatedly determine & improve individual risk of progression, w/ patients who get upstaged to a high-risk category having increased chance of progression: https://t.co/5E9cZU0nJi. #mmsm
So lucky to work with Peter @10000Donors and his family, whose fundraising efforts are making the North East Myeloma Genome project possible!
Catch us on BBC North tonight https://t.co/wRVMQxkLGN
Thank you to everyone involved! @profghjackson & NuTH team, @4130chromo@NU_Cancer
NOW OPEN: The MMRF is accepting applications for our 2024 Research Fellows Award Program. Successful applicants will receive up to $150,000 in research funding over two years. For details click/tap on the “Projects and Awards” anchor link on this page: https://t.co/5OPTk7l38H
#Myeloma Paper of the Day: Single cell multi-omic ATAC- and RNA-seq dataset links one plasma cell subtype with myeloma progression associated with chromosome 1q alterations, TP53 mutations, and higher expression of PHF19, an epigenetic regulator: https://t.co/ShJmZirCkp.